Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Astec LifeSciences Limited (NSE: ASTEC), ISIN INE563J01010 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
ASTEC last traded at ₹757.75 (-4.55%), with a 52-week range of ₹512.35 to ₹936.00 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 71.96%, FIIs 0.01%, DIIs 3.33%, mutual funds 3.02%.
EquiSense Score (ECS): 58/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.